Beximco Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Iqbal Ahmed
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 39.9yrs |
| CEO ownership | n/a |
| Management average tenure | 15.6yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Iqbal Ahmed
39.9yrs
Tenure
Mr. Iqbal U. Ahmed is MD of Beximco Pharmaceuticals Limited and serves as its Director since 1985. has been a Director of Shinepukur Ceramics Limited since August 24, 2012 and Non-Executive Director at Ban...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | no data | no data | no data | |
| Chief Financial Officer | 15.9yrs | no data | no data | |
| Chief Operating Officer | 15.6yrs | no data | no data | |
| Director of Accounts & Finance | no data | no data | no data | |
| Director of Marketing | no data | no data | no data | |
| General Manager of Human Resources | no data | no data | no data | |
| Head of Distribution Services & Director of International Marketing | 14.9yrs | no data | no data | |
| Company Secretary & Executive Director | no data | no data | no data |
15.6yrs
Average Tenure
Experienced Management: R2WA's management team is seasoned and experienced (15.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 39.9yrs | no data | no data | |
| Company Secretary & Executive Director | no data | no data | no data | |
| Vice Chairman | no data | no data | 2.04% € 6.2m | |
| Director | 31.9yrs | no data | no data | |
| Director | no data | no data | no data | |
| Chairman | no data | no data | 2.03% € 6.1m | |
| Non-Executive Director | 4.1yrs | no data | no data | |
| Independent Non-Executive Director | 4.4yrs | no data | no data | |
| Non-Executive Director | 4.1yrs | no data | no data | |
| Independent Director | 3.9yrs | no data | no data |
4.3yrs
Average Tenure
64yo
Average Age
Experienced Board: R2WA's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 17:22 |
| End of Day Share Price | 2024/12/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beximco Pharmaceuticals Limited is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Md. Islam | BRAC EPL Stock Brokerage Ltd |
| Asif Khan | EDGE Research & Consulting |
| Lorenza Castellon | Equity Development Limited |